Table 1.
Patient and tumor characteristics.
| Variable | All cases | HR + HER2- | TNBC | HR + HER2+ | HR - HER2+ |
|---|---|---|---|---|---|
| All cases, N (%) | 4,895 (100) | 2,549 (52.1) | 1,863 (38.1) | 263 (5.4) | 220 (4.5) |
| Female cases, N (%) | 4,845 (99) | 2,515 (98.7) | 1,851 (99.4) | 261 (99.2) | 218 (99.1) |
| Male cases, N (%) | 50 (1) | 34 (1.3) | 12 (0.6) | 2 (0.8) | 2 (0.9) |
| Median age, years (SD) | 58 (12.8) | 59 (12.5) | 57 (13.1) | 55 (12.9) | 55 (12.3) |
| Age range (year) | 17–90 | 17–90 | 19–90 | 19–90 | 26–90 |
| Primary site, N (%) | 1,921 (39.2) | 889 (34.9) | 831 (44.6) | 111 (42.2) | 90 (40.9) |
| Metastatic site, N (%) | 2,974 (60.8) | 1,660 (65.1) | 1,032 (55.4) | 152 (57.8) | 130 (59.1) |